英国IgG4相关疾病队列中肾脏与腹膜后受累的临床表现及长期结局
该多中心回顾性队列研究纳入154例IgG4相关疾病患者,其中14例(9.1%)有IgG4相关肾病、10例(6.5%)有腹膜后纤维化、4例(2.6%)两者兼有。肾活检最常见为IgG4+浆细胞丰富的肾小管间质性肾炎(93.3%),多数接受糖皮质激素治疗,随访60±48个月期间46.4%复发,20.8%肾功能恶化,8.3%进展至终末期肾病。
要点
- IgG4-RKD与IgG4-RPF是IgG4-RD的重要器官表现,应早期识别并治疗以防进展至ESRD。
- 肾活检以IgG4+浆细胞丰富的肾小管间质性肾炎最常见,可伴膜性肾病。
- 随访期间近半数患者复发,多数复发累及肾脏,部分患者肾功能恶化。
核心结论
- IgG4-RKD和IgG4-RPF是IgG4-RD的主要器官表现,应早期识别并及时治疗以预防进展至终末期肾病。
研究设计与样本
- 多中心回顾性观察性研究,纳入154例IgG4-RD患者,其中14例IgG4-RKD、10例IgG4-RPF、4例两者兼有,通过病历回顾收集基线临床、组织学、影像学、治疗及结局数据。
主要发现
- 154例IgG4-RD中,14例(9.1%)有IgG4-RKD,10例(6.5%)有IgG4-RPF,4例(2.6%)两者兼有。
- 患者年龄58.2±14.2岁,26例(92.9%)为男性。
- 有内在肾脏疾病者就诊时肌酐更差(229 μmol/l vs. 110 μmol/l;P = 0.0076)。
- 87.5%患者血清IgG4升高,半数IgG4-RKD患者存在低补体血症。
- 15例接受肾活检,14例(93.3%)为IgG4+浆细胞丰富的肾小管间质性肾炎,4例(26.7%)有膜性肾病。
关键数值与推荐
- 89.3%患者接受糖皮质激素治疗,4例(16.0%)初始加用硫唑嘌呤。
- 5例(20.8%)肾功能恶化,其中2例(8.3%)达到终末期肾病。
临床怎么用
- 对IgG4-RD患者应评估肾脏和腹膜后受累,早期识别IgG4-RKD和IgG4-RPF并及时启动治疗以预防ESRD。
- 肾活检有助于明确IgG4-RKD病理类型,常见为IgG4+浆细胞丰富的肾小管间质性肾炎,可伴膜性肾病。
- 治疗以糖皮质激素为主,部分患者可加用硫唑嘌呤;随访中需监测复发,尤其是肾脏复发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: IgG4-related disease (IgG4-RD) is a relapsing multisystem fibro-inflammatory disease, which may involve the kidney (IgG4-related kidney disease [IgG4-RKD]) and retroperitoneum (IgG4-related retroperitoneal fibrosis [IgG4-RPF]). The aim of this study was to describe IgG4-RKD and IgG4-RPF in the United Kingdom. METHODS: We conducted a retrospective observational study of patients with IgG4-RKD and IgG4-RPF in a multicenter IgG4-RD cohort. Data were collected through review of medical records. We describe clinical parameters at baseline, histological and radiological findings, treatment, and patient outcomes. RESULTS: Of 154 patients with IgG4-RD, 14 (9.1%) had IgG4-RKD, 10 (6.5%) had IgG4-RPF, and 4 (2.6%) had both. Patients were aged 58.2 ± 14.2 years, and 26 (92.9%) were male. Creatinine at presentation was worse in those with intrinsic renal disease (229 μmol/l vs. 110 μmol/l; P = 0.0076). Serum IgG4 was elevated in the majority of patients (87.5%), and hypocomplementemia was present in half of those with IgG4-RKD. Fifteen patients underwent renal biopsy; tubulointerstitial nephritis with abundant IgG4+ plasma cells was the most common finding (n = 14; 93.3%), and 4 (26.7%) patients had membranous nephropathy. Most patients (89.3%) were treated with corticosteroids, and 4 (16.0%) with additional azathioprine as initial management. Thirteen patients (46.4%) relapsed over 60 ± 48 months of follow-up, at median 18 (12-36) months after renal/RPF diagnosis; 61.5% of relapses were in the kidney. Renal function deteriorated in 5 patients (20.8%), including 2 (8.3%) who reached end-stage renal disease (ESRD). CONCLUSION: IgG4-RKD and IgG4-RPF represent major organ manifestations of IgG4-RD, and should be identified early with prompt treatment to prevent progression to ESRD.
引用
- Evans RDR, Cargill T, Goodchild G, et al. Clinical Manifestations and Long-term Outcomes of IgG4-Related Kidney and Retroperitoneal Involvement in a United Kingdom IgG4-Related Disease Cohort. Kidney Int Rep. 2018. PMID: 30596168. doi:10.1016/j.ekir.2018.08.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。